Literature DB >> 2052600

Negative charge at the casein kinase II phosphorylation site is important for transformation but not for Rb protein binding by the E7 protein of human papillomavirus type 16.

J M Firzlaff1, B Lüscher, R N Eisenman.   

Abstract

The human papillomavirus E7 protein is phosphorylated at the two serines in positions 31/32, which are part of a consensus sequence for casein kinase II (CKII). In this study, we have investigated the effect of CKII phosphorylation site mutations, all of which lead to unphosphorylated E7 proteins. The replacement of the two serines by uncharged alanine residues drastically reduced the ability of E7 to cotransform primary cells with ras, whereas negatively charged aspartic acid at the same positions produced only a slight effect. This difference was not reflected in the p105Rb binding or the E2 promoter transactivation capability of these two mutants. Mutations that changed the CKII consensus without altering the serine residues also resulted in a loss of phosphorylation and transformation. This indicated that negative charge at positions 31/32 provided either by phosphorylation or by a negatively charged amino acid is necessary for efficient transformation without significantly affecting p105Rb binding or transactivation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2052600      PMCID: PMC51837          DOI: 10.1073/pnas.88.12.5187

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Association of catalytic and regulatory subunits of cyclic AMP-dependent protein kinase requires a negatively charged side group at a conserved threonine.

Authors:  L R Levin; M J Zoller
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

2.  Mutational analysis of human papillomavirus type 16 E7 functions.

Authors:  S Watanabe; T Kanda; H Sato; A Furuno; K Yoshiike
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

3.  Human papillomavirus type 16 E7 protein expressed in Escherichia coli and monkey COS-1 cells: immunofluorescence detection of the nuclear E7 protein.

Authors:  H Sato; S Watanabe; A Furuno; K Yoshiike
Journal:  Virology       Date:  1989-05       Impact factor: 3.616

4.  The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes.

Authors:  K Münger; W C Phelps; V Bubb; P M Howley; R Schlegel
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

5.  The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product.

Authors:  N Dyson; P M Howley; K Münger; E Harlow
Journal:  Science       Date:  1989-02-17       Impact factor: 47.728

6.  The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties.

Authors:  J R Gage; C Meyers; F O Wettstein
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

7.  The region of the HPV E7 oncoprotein homologous to adenovirus E1a and Sv40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation.

Authors:  M S Barbosa; C Edmonds; C Fisher; J T Schiller; D R Lowy; K H Vousden
Journal:  EMBO J       Date:  1990-01       Impact factor: 11.598

8.  HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes.

Authors:  P Hawley-Nelson; K H Vousden; N L Hubbert; D R Lowy; J T Schiller
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

9.  Myc oncoproteins are phosphorylated by casein kinase II.

Authors:  B Lüscher; E A Kuenzel; E G Krebs; R N Eisenman
Journal:  EMBO J       Date:  1989-04       Impact factor: 11.598

10.  Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product.

Authors:  K Münger; B A Werness; N Dyson; W C Phelps; E Harlow; P M Howley
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

View more
  34 in total

1.  Intranuclear localization of human papillomavirus 16 E7 during transformation and preferential binding of E7 to the Rb family member p130.

Authors:  K Smith-McCune; D Kalman; C Robbins; S Shivakumar; L Yuschenkoff; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

2.  Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein.

Authors:  W C Phelps; K Münger; C L Yee; J A Barnes; P M Howley
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

Review 3.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

4.  Inhibition of human papillomavirus type 16 E7 phosphorylation by the S100 MRP-8/14 protein complex.

Authors:  Sharof Tugizov; Jennifer Berline; Rossana Herrera; Maria Elena Penaranda; Mayumi Nakagawa; Joel Palefsky
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 5.  The human papillomavirus E7 oncoprotein as a regulator of transcription.

Authors:  William K Songock; Seong-Man Kim; Jason M Bodily
Journal:  Virus Res       Date:  2016-11-08       Impact factor: 3.303

6.  Regulation of the human papillomavirus oncoproteins by differential phosphorylation.

Authors:  P Massimi; D Pim; C Kühne; L Banks
Journal:  Mol Cell Biochem       Date:  2001-11       Impact factor: 3.396

7.  Characterization of a human TSPY promoter.

Authors:  Britta Skawran; Stephanie Schubert; Frank Dechend; Jörg Vervoorts; Karim Nayernia; Bernhard Lüscher; Jörg Schmidtke
Journal:  Mol Cell Biochem       Date:  2005-08       Impact factor: 3.396

8.  The binding domain structure of retinoblastoma-binding proteins.

Authors:  J Figge; K Breese; S Vajda; Q L Zhu; L Eisele; T T Andersen; R MacColl; T Friedrich; T F Smith
Journal:  Protein Sci       Date:  1993-02       Impact factor: 6.725

9.  Positive and negative regulation of cell proliferation by E2F-1: influence of protein level and human papillomavirus oncoproteins.

Authors:  R M Melillo; K Helin; D R Lowy; J T Schiller
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

10.  Phosphorylation-dependent formation of a quaternary complex at the c-fos SRE.

Authors:  H Gille; M Kortenjann; T Strahl; P E Shaw
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.